INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

1,829 studies · page 7 of 77

2017 / Systematic review and meta-analysis of trials

Chronic ingestion of licorice products containing glycyrrhizic acid significantly increased blood pressure and reduced plasma potassium in a meta-analysis.

A systematic review and meta-analysis of 18 trials (n=337) evaluated the effects of chronic ingestion of products containing at least 100 mg of glycyrrhizic acid daily. Licorice ingestion significantly increased mean systolic blood pressure by 5.45 mm Hg (95% CI 3.51-7.39) and diastolic blood pressure by 3.19 mm Hg (95% CI 0.10-6.29). Significant decreases occurred in plasma potassium (-0.33 mmol l-1, 95% CI -0.42 to 0.23), plasma renin activity (-0.82 ng ml-1 per hour, 95% CI -1.27 to -0.37), and plasma aldosterone (-173.24 pmol l-1, 95% CI -231.65 to -114.83). Daily dose correlated significantly with systolic (r2=0.55) and diastolic blood pressure (r2=0.65).

Penninkilampi R, Eslick EM, Eslick GD J Hum Hypertens, 2017. PMID 28660884

2017 / Systematic review and meta-analysis of randomized controlled trials

B-vitamin supplements modestly reduced stroke risk but did not affect myocardial infarction or death.

An updated systematic review analyzed 15 randomized controlled trials with 71,422 participants evaluating vitamin B6, B9, or B12 supplements over 1 to 7.3 years. Compared to placebo, homocysteine-lowering interventions reduced stroke (4.3% vs. 5.1%; RR 0.90, 95% CI 0.82-0.99; 10 trials, n=44,224). However, no differences occurred for myocardial infarction (RR 1.02, 95% CI 0.95-1.10), all-cause mortality (RR 1.01, 95% CI 0.96-1.06), or serious adverse events (RR 1.07, 95% CI 1.00-1.14).

Martí-Carvajal AJ, Solà I, Lathyris D, et al. Cochrane Database Syst Rev, 2017. PMID 28816346

2017 / Umbrella review of meta-analyses of observational studies and RCTs

Coffee consumption was linked to a lower risk of multiple cancers, cardiovascular disease, mortality, Parkinson's disease, and type-2 diabetes.

An umbrella review evaluated evidence from meta-analyses of observational studies and randomized controlled trials on coffee and caffeine consumption. Across 112 observational meta-analyses covering 59 unique outcomes, coffee was associated with a probable decreased risk of breast, colorectal, colon, endometrial, and prostate cancers, cardiovascular disease and mortality, Parkinson's disease, and type-2 diabetes. Across 20 observational meta-analyses covering 14 unique outcomes, caffeine was associated with a probable decreased risk of Parkinson's disease and type-2 diabetes, but an increased risk of pregnancy loss. Among 9 RCT meta-analyses examining 12 acute outcomes, coffee was associated with elevated serum lipids (affected by significant heterogeneity) and caffeine with elevated blood pressure.

Shows an association, not proof of cause and effect.

Grosso G, Godos J, Galvano F, et al. Annu Rev Nutr, 2017. PMID 28826374

2017 / Meta-analysis of prospective cohorts

Fish and omega-3 fatty acid intake are not linked to atrial fibrillation risk.

A meta-analysis of seven prospective cohort studies examined dietary intakes and incident atrial fibrillation. Across 206,811 participants and 12,913 cases, the summary relative risk comparing the highest with lowest consumption categories was 1.01 (95% CI: 0.94-1.09) for fish and 1.03 (95% CI: 0.97-1.09) for long-chain n-3 polyunsaturated fatty acids. Subgroup and dose-response evaluations consistently showed similar null associations.

Shows an association, not proof of cause and effect.

Li FR, Chen GC, Qin J, et al. Nutrients, 2017. PMID 28850090

2017 / Systematic review and dose-response meta-analysis

Both short and long sleep durations were linked to higher risks of all-cause mortality and cardiovascular events, with lowest risk at about 7 hours per day.

A systematic review and dose-response meta-analysis of prospective cohort studies examined sleep duration and risks of mortality and cardiovascular outcomes. U-shaped associations were observed for all outcomes, with the lowest risk at approximately 7 hours of sleep per day. For sleep <7 hours/day, each 1-hour reduction had a pooled RR of 1.06 (95% CI, 1.04-1.07) for all-cause mortality, 1.06 (95% CI, 1.03-1.08) for total CVD, 1.07 (95% CI, 1.03-1.12) for CHD, and 1.05 (95% CI, 1.01-1.09) for stroke. For sleep >7 hours/day, each 1-hour increment had a pooled RR of 1.13 (95% CI, 1.11-1.15) for all-cause mortality, 1.12 (95% CI, 1.08-1.16) for total CVD, 1.05 (95% CI, 1.00-1.10) for CHD, and 1.18 (95% CI, 1.14-1.21) for stroke.

Shows an association, not proof of cause and effect.

Yin J, Jin X, Shan Z, et al. J Am Heart Assoc, 2017. PMID 28889101

2017 / Systematic review of randomized crossover trials

Dietary nitrate may enhance physiological performance in older adults, but other benefits vary.

A systematic review evaluated 12 randomized crossover controlled trials investigating food-based nitrate supplementation in older adults. Four trials reported enhanced physiological endurance measured by time to exhaustion. Cardiovascular outcomes were mixed, with six studies noting improved blood pressure or flow while six showed no effect, and studies examining metabolic health demonstrated no clear benefits.

Stanaway L, Rutherfurd-Markwick K, Page R, et al. Nutrients, 2017. PMID 29077028

2017 / Umbrella review of meta-analyses

Coffee consumption was linked to lower risks of all-cause mortality, cardiovascular disease, and cancer, though pregnancy harms were observed.

An umbrella review analyzed 201 meta-analyses of observational studies and 17 meta-analyses of interventional studies on coffee and multiple health outcomes. Intakes of 3 to 4 cups a day versus none showed the largest relative risk reductions for all-cause mortality (RR 0.83, 95% CI 0.79 to 0.88), cardiovascular mortality (RR 0.81, 95% CI 0.72 to 0.90), and cardiovascular disease (RR 0.85, 95% CI 0.80 to 0.90). High versus low intake was linked to lower incident cancer risk (RR 0.82, 95% CI 0.74 to 0.89) alongside lower risk of neurological, metabolic, and liver conditions. Conversely, high consumption during pregnancy was linked to higher risk of low birth weight (OR 1.31), preterm birth, and pregnancy loss, and coffee was associated with fracture risk in women.

Shows an association, not proof of cause and effect.

Poole R, Kennedy OJ, Roderick P, et al. BMJ, 2017. PMID 29167102

2017 / Systematic review and meta-analysis of randomized controlled trials

Nut intake improved flow-mediated dilation but did not consistently alter inflammatory markers.

A meta-analysis of 32 randomized controlled trials lasting 3 weeks or longer evaluated the impact of tree nut or peanut intake. Nut consumption significantly increased flow-mediated dilation (weighted mean difference: 0.79%, 95% CI 0.35 to 1.23; 8 studies, 652 participants). However, non-significant differences were observed for C-reactive protein (WMD: -0.01 mg/L, 95% CI -0.06 to 0.03; 25 studies) and other biomarkers of inflammation.

Neale EP, Tapsell LC, Guan V, et al. BMJ Open, 2017. PMID 29170286

2017 / Meta-analysis of randomized controlled trials

Replacing animal protein with plant protein lowered LDL, non-HDL cholesterol, and apolipoprotein B.

A meta-analysis of 112 randomized controlled trials of at least 3 weeks evaluated the effects of substituting plant for animal protein on blood lipids. The replacement lowered low-density lipoprotein cholesterol by 0.16 mmol/L (95% CI: -0.20 to -0.12) and reduced non-HDL cholesterol levels by 0.18 mmol/L (95% CI: -0.22 to -0.14). Apolipoprotein B also fell by 0.05 g/L (95% CI: -0.06 to -0.03).

Li SS, Blanco Mejia S, Lytvyn L, et al. J Am Heart Assoc, 2017. PMID 29263032

2017 / Umbrella review of meta-analyses

Higher dietary fiber intake was linked to lower risks of cardiovascular disease incidence and mortality across meta-analyses.

An umbrella review analyzed 31 published meta-analyses to examine the relationship between dietary fiber and cardiovascular disease. All meta-analyses comparing highest versus lowest fiber intake reported significant relative risk reductions for cardiovascular disease mortality (RR = 0.77-0.83), cardiovascular disease incidence (RR = 0.72-0.91), coronary heart disease (RR = 0.76-0.93), and stroke (RR = 0.83-0.93). Additionally, meta-analyses of supplementation studies using β-glucan or psyllium fibers found significant reductions in total serum cholesterol (9.3 to 14.7 mg/dL) and LDL cholesterol concentrations (10.8 to 13.5 mg/dL).

McRae MP J Chiropr Med, 2017. PMID 29276461

2016 / Systematic review and meta-analysis of randomized controlled trials

Flaxseed supplements reduce systolic and diastolic blood pressure in randomized controlled trials

A meta-analysis of 15 randomized trials comprising 1,302 subjects found that flaxseed products significantly lowered systolic blood pressure (WMD: -2.85 mmHg, 95% CI: -5.37 to -0.33, p = 0.027) and diastolic blood pressure (WMD: -2.39 mmHg, 95% CI: -3.78 to -0.99, p = 0.001). Systolic drops were significant with powder but not oil or lignans, whereas diastolic declines occurred with both powder and oil forms.

Ursoniu S, Sahebkar A, Andrica F, et al. Clin Nutr, 2016. PMID 26071633

2016 / Meta-analysis of randomized controlled trials

Niacin therapy is associated with a moderately increased risk of new-onset diabetes in randomized controlled trials.

A meta-analysis of 11 randomized controlled trials evaluated the link between niacin therapy and new-onset diabetes in 26,340 non-diabetic participants over a weighted mean follow-up of 3.6 years. In total, 1,371 participants developed diabetes (725 of 13,121 assigned to niacin vs 646 of 13,219 controls). Niacin was associated with a significantly higher risk of new-onset diabetes (RR 1.34, 95% CI 1.21 to 1.49; I2 = 0.0%), equating to one extra diabetes case per 43 participants treated for 5 years. Results remained consistent regardless of background statin therapy (p = 0.88) or combination with laropiprant (p = 0.52).

Goldie C, Taylor AJ, Nguyen P, et al. Heart, 2016. PMID 26370223

2016 / Updated meta-analysis and review of randomized controlled trials

Garlic preparations reduced systolic and diastolic blood pressure, with larger reductions seen in hypertensive individuals.

Researchers updated a meta-analysis of randomized controlled trials evaluating the effect of garlic preparations on blood pressure and reviewed its effects on cholesterol and immunity. In 20 trials with 970 participants, garlic decreased systolic blood pressure by a mean ± SE of 5.1 ± 2.2 mm Hg (P < 0.001) and diastolic blood pressure by 2.5 ± 1.6 mm Hg (P < 0.002) compared with placebo. In trials of hypertensive subjects, reductions were larger: 8.7 ± 2.2 mm Hg for SBP (P < 0.001; n = 10) and 6.1 ± 1.3 mm Hg for DBP (P < 0.001; n = 6). A previously published meta-analysis cited in the review noted a 10% reduction in total and LDL cholesterol when taken for >2 months by individuals with slightly elevated levels, and clinical trials showed reductions in upper respiratory infections.

Ried K J Nutr, 2016. PMID 26764326

2016 / Systematic review and meta-analysis of randomized controlled trials

Nigella sativa supplementation reduced total cholesterol, LDL cholesterol, and triglyceride levels in trials.

A meta-analysis of 17 randomized controlled trials evaluated the effects of Nigella sativa supplementation on plasma lipids. Supplementation significantly reduced total cholesterol (WMD -15.65 mg/dL, 95% CI -24.67 to -6.63), LDL cholesterol (WMD -14.10 mg/dL, 95% CI -19.32 to -8.88), and triglycerides (WMD -20.64 mg/dL, 95% CI -30.29 to -11.00). Overall HDL cholesterol did not change significantly (WMD 0.28 mg/dL, 95% CI -1.96 to 2.53), though seed powder alone increased it.

Sahebkar A, Beccuti G, Simental-Mendía LE, et al. Pharmacol Res, 2016. PMID 26875640

2016 / Meta-analysis of randomized clinical trials

Diets enriched with avocado significantly lowered total cholesterol, LDL cholesterol, and triglycerides.

A meta-analysis of 10 randomized trials encompassing 229 participants evaluated the impact of avocado-substituted diets on circulating lipid markers. Avocado consumption reduced total cholesterol by -18.80 mg/dL (95% CI, -24.56 to -13.05), LDL cholesterol by -16.50 mg/dL (95% CI, -22.91 to -10.10), and triglycerides by -27.20 mg/dL (95% CI, -44.41 to -9.99). High-density lipoprotein cholesterol changed non-significantly by -0.18 mg/dL (95% CI, -3.23 to 2.88).

Peou S, Milliard-Hasting B, Shah SA J Clin Lipidol, 2016. PMID 26892133

2016 / Systematic review and meta-analysis of randomized controlled trials

Weight loss diets reduced blood pressure and body weight in adults with hypertension.

In a systematic review of eight randomized trials with 2,100 adults with primary hypertension, dietary weight loss interventions lasting 6 to 36 months lowered systolic blood pressure by -4.5 mm Hg (95% CI -7.2 to -1.8 mm Hg) and diastolic blood pressure by -3.2 mm Hg (95% CI -4.8 to -1.5 mm Hg). Participants on weight-reducing diets also lost weight compared to controls (mean difference -4.0 kg, 95% CI -4.8 to -3.2 kg). Effects on mortality and morbidity remain unknown.

Semlitsch T, Jeitler K, Berghold A, et al. Cochrane Database Syst Rev, 2016. PMID 26934541

2016 / Meta-analysis of prospective cohorts

Higher saturated fat intake was associated with reduced total and fatal stroke risks

A meta-analysis evaluated 15 prospective cohort studies including 476,569 individuals and 11,074 strokes. Greater saturated fat consumption was linked to lower overall stroke risk (RR 0.89, 95% CI: 0.82-0.96) and fatal stroke risk (RR 0.75, 95% CI: 0.59-0.94). Subgroup reductions appeared in East-Asians, men, individuals with BMI under 24, and intakes under 25 g/day, but not in non-East-Asians, women, or higher intake groups.

Shows an association, not proof of cause and effect.

Cheng P, Wang J, Shao W, et al. Neurol Sci, 2016. PMID 26979840

2016 / Meta-analysis with trial sequential analysis of RCTs

Berry consumption significantly reduced LDL-cholesterol, systolic blood pressure, fasting glucose, BMI, HbA1c, and TNF-α in a meta-analysis of RCTs.

A meta-analysis with trial sequential analysis of 22 RCTs (1,251 subjects) evaluated the effects of berry consumption in healthy individuals and patients with CVD. Berry consumption significantly lowered LDL-cholesterol (WMD -0.21 mmol/L; 95% CI -0.34 to -0.07; P = 0.003), systolic blood pressure (WMD -2.72 mmHg; 95% CI -5.32 to -0.12; P = 0.04), fasting glucose (WMD -0.10 mmol/L; 95% CI -0.17 to -0.03; P = 0.004), and BMI (WMD -0.36 kg/m2; 95% CI -0.54 to -0.18; P < 0.00001). It also significantly reduced HbA1c (WMD -0.20%; P = 0.04) and TNF-α (WMD -0.99 pg/mL; P = 0.04), while other markers showed no significant changes.

Huang H, Chen G, Liao D, et al. Sci Rep, 2016. PMID 27006201

2016 / Meta-analysis of prospective cohort studies

Higher whole grain intake was linked to lower risks of total, cardiovascular, and cancer mortality in a meta-analysis of prospective cohorts.

A meta-analysis evaluated 14 prospective cohort studies comprising 786,076 participants with 97,867 total deaths, 23,957 CVD deaths, and 37,492 cancer deaths. Comparing extreme categories (high vs. low intake), pooled relative risks were 0.84 (95% CI, 0.80-0.88) for total mortality, 0.82 (95% CI, 0.79-0.85) for CVD mortality, and 0.88 (95% CI, 0.83-0.94) for cancer mortality. Dose-response analysis demonstrated monotonic associations, where each 16-g/d increase in whole grains was associated with relative risks of 0.93 (95% CI, 0.92-0.94) for total mortality, 0.91 (95% CI, 0.90-0.93) for CVD mortality, and 0.95 (95% CI, 0.94-0.96) for cancer mortality.

Shows an association, not proof of cause and effect.

Zong G, Gao A, Hu FB, et al. Circulation, 2016. PMID 27297341

2016 / Dose-response meta-analysis of prospective studies

Higher whole grain intake was linked to lower risks of cardiovascular disease, total cancer, and all-cause mortality in prospective studies.

A systematic review and dose-response meta-analysis evaluated 45 prospective studies examining whole grain consumption and disease or mortality risks. A 90 g/day increase in whole grain intake was associated with a lower relative risk of coronary heart disease (RR 0.81, 95% CI 0.75 to 0.87), cardiovascular disease (RR 0.78, 95% CI 0.73 to 0.85), total cancer mortality (RR 0.85, 95% CI 0.80 to 0.91), and all-cause mortality (RR 0.83, 95% CI 0.77 to 0.90). Risk reductions were also seen for respiratory, infectious, and all non-cardiovascular non-cancer mortality, with risk reductions seen up to 210-225 g/day for most outcomes. Little evidence of an association was found for refined grains, white rice, total rice, or total grains.

Shows an association, not proof of cause and effect.

Aune D, Keum N, Giovannucci E, et al. BMJ, 2016. PMID 27301975

2016 / Meta-analysis of prospective clinical studies

Acute energy drink consumption raised systolic and diastolic blood pressure in clinical studies.

A meta-analysis of 15 prospective clinical studies evaluated hemodynamic outcomes after acute energy drink intake. Systolic blood pressure increased significantly by 4.44 mm Hg (95% CI 2.71 to 6.17; n = 340) and diastolic pressure rose by 2.73 mm Hg (95% CI 1.52 to 3.95; n = 322). Heart rate changes were not statistically significant (0.80 beats per minute, 95% CI -1.26 to 2.87), while drinks delivering at least 200 mg caffeine raised systolic pressure by 6.44 mm Hg.

Shah SA, Chu BW, Lacey CS, et al. Ann Pharmacother, 2016. PMID 27340146

2016 / Systematic review and meta-analysis of prospective cohorts

Butter consumption shows relatively small or neutral associations with mortality, CVD, and diabetes

A meta-analysis of 15 country-specific prospective cohorts with 636,151 participants evaluated butter intake over 6.5 million person-years. Each daily 14-gram serving was linked to a slight rise in all-cause mortality (RR = 1.01, 95% CI: 1.00 to 1.03) and a small decrease in diabetes risk (RR = 0.96, 95% CI: 0.93 to 0.99). No significant associations were observed for cardiovascular disease, coronary heart disease, or stroke.

Shows an association, not proof of cause and effect.

NANO counterpoint →

Pimpin L, Wu JH, Haskelberg H, et al. PLoS One, 2016. PMID 27355649

2016 / Systematic review of prospective observational studies

Evidence did not convincingly link potato intake with obesity, diabetes, or cardiovascular risk.

A systematic review examined 13 observational studies investigating potato consumption and risks of adiposity, type 2 diabetes, and cardiovascular disease in healthy adults. Total potato intake showed neutral or mixed links with adiposity and diabetes, with no observed association for cardiovascular disease. However, french fries were positively associated with increased adiposity across 3 studies and with type 2 diabetes across 3 studies.

Shows an association, not proof of cause and effect.

Borch D, Juul-Hindsgaul N, Veller M, et al. Am J Clin Nutr, 2016. PMID 27413134

2016 / Meta-analysis of randomized controlled trials

A meta-analysis found fenugreek significantly reduced fasting blood glucose, 2-hour blood glucose, HbA1c, and total cholesterol in diabetes and prediabetes.

A meta-analysis of 10 articles (12 randomized controlled trials) evaluated the effects of fenugreek on glycemic and lipid parameters in diabetes and prediabetes. Pooled results showed fenugreek significantly reduced fasting blood glucose (MD -0.84 mmol/L; 95% CI -1.38 to -0.31; p=0.002), 2-hour postprandial glucose (MD -1.30 mmol/L; 95% CI -1.78 to -0.83; p<0.0001), HbA1c (MD -1.16; 95% CI -1.23 to -1.09; p<0.00001), and total cholesterol (MD -0.30 mmol/L; 95% CI -0.56 to -0.03; p=0.03). Changes in triglycerides, LDL-c, and HDL-c were not statistically significant or required further verification. No liver or kidney toxicity was reported, with gastrointestinal discomfort being the main side effect, though some included studies were of low quality.

Gong J, Fang K, Dong H, et al. J Ethnopharmacol, 2016. PMID 27496582